BiotechTube

Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Clinical Pharmacology

Conditions

Clinical Pharmacology

Trial Timeline

Jan 24, 2019 → May 13, 2019

NCT ID
NCT04511611

About Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form

Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form is a phase 1 stage product being developed by Bayer for Clinical Pharmacology. The current trial status is completed. This product is registered under clinical trial identifier NCT04511611. Target conditions include Clinical Pharmacology.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT04511611Phase 1Completed
NCT04511637Phase 1Completed

Competing Products

20 competing products in Clinical Pharmacology

See all competitors
ProductCompanyStageHype Score
Lecanemab + PlaceboEisaiPhase 3
77
Cetuximab + CisplatinEli LillyPhase 2
52
Durvalumab + TremelimumabAstraZenecaPhase 1/2
41
PosaconazoleMerckApproved
85
Rebif®MerckPhase 3
77
Blinatumomab + olverembatinibAmgenPhase 2
51
Binimetinib + NivolumabBristol Myers SquibbPhase 2
51
Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM)BayerPhase 1
30
Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspra®) + PlaceboBayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)BayerPhase 1
30
Fulacimstat (BAY1142524)BayerPhase 1
30
Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon PlaceboBayerPhase 1
30
Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetilBayerPhase 1
30
BAY1817080 + Placebo + ItraconazoleBayerPhase 1
30
BAY1902607 + PlaceboBayerPhase 1
30
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)BayerPhase 1
30
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + PlaceboBayerPhase 1
30
Neladenoson bialanate (BAY 1067197)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82